PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

Core Viewpoint - PROCEPT BioRobotics is focused on advancing patient care in urology through innovative robotic solutions, particularly in the treatment of benign prostatic hyperplasia (BPH) [3]. Company Overview - PROCEPT BioRobotics manufactures the AQUABEAM and HYDROS Robotic Systems, with the HYDROS system being the only AI-powered technology delivering Aquablation therapy [3]. - The company aims to revolutionize BPH treatment globally in partnership with urologists, emphasizing the delivery of effective, safe, and durable outcomes for men suffering from lower urinary tract symptoms (LUTS) due to BPH [3]. - BPH affects approximately 40 million men in the United States, highlighting the significant market potential for the company's solutions [3]. - The company has developed a substantial body of clinical evidence, with over 150 peer-reviewed publications supporting the benefits and clinical advantages of Aquablation therapy [3]. Upcoming Events - Management will present at the 37th Annual Piper Sandler Healthcare Conference in New York City on December 2 at 8:30 a.m. Eastern Time [1]. - A live webcast of the event will be available on the company's website, with recordings archived for at least 90 days [2].